影响重症肺炎患者预后的相关因素分析及构建nomogram预测模型的价值研究

殷菲. 影响重症肺炎患者预后的相关因素分析及构建nomogram预测模型的价值研究[J]. 临床急诊杂志, 2020, 21(10): 819-825. doi: 10.13201/j.issn.1009-5918.2020.10.011
引用本文: 殷菲. 影响重症肺炎患者预后的相关因素分析及构建nomogram预测模型的价值研究[J]. 临床急诊杂志, 2020, 21(10): 819-825. doi: 10.13201/j.issn.1009-5918.2020.10.011
YIN Fei. Analysis of relevant factors affecting the prognosis of patients with severe pneumonia and research on the value of establishing nomogram prediction model[J]. J Clin Emerg, 2020, 21(10): 819-825. doi: 10.13201/j.issn.1009-5918.2020.10.011
Citation: YIN Fei. Analysis of relevant factors affecting the prognosis of patients with severe pneumonia and research on the value of establishing nomogram prediction model[J]. J Clin Emerg, 2020, 21(10): 819-825. doi: 10.13201/j.issn.1009-5918.2020.10.011

影响重症肺炎患者预后的相关因素分析及构建nomogram预测模型的价值研究

  • 基金项目:

    苏州市第九人民医院院级科研项目(No:YK202032)

详细信息
    通讯作者: 殷菲,E-mail:yinfxyz@163.com
  • 中图分类号: R459.7

Analysis of relevant factors affecting the prognosis of patients with severe pneumonia and research on the value of establishing nomogram prediction model

More Information
  • 目的:分析和筛选影响重症肺炎患者预后的相关因素,构建nomogram预测模型,并评估模型的临床应用价值。方法:选用2014-12-2019-12期间入住苏州市第九人民医院ICU的124例重症肺炎患者,根据预后情况分为预后良好组(n=61)和预后不良组(n=63)。采用单因素分析和多因素Logistic回归分析筛选影响预后的相关因素,构建预测模型,绘制nomogram列线图,并验证模型的区分度和校准度。再通过绘制预测模型、APACHEⅡ评分、SOFA评分、PSI评分、CURB-65评分的ROC曲线,计算各曲线的截断值、敏感度、特异度、AUC。利用AUC及NRI、IDI等指标对预测模型与APACHEⅡ评分、SOFA评分、PSI评分、CURB-65评分进行比较,评价新模型在预测预后方面的改善效果。结果:平均动脉压(MAP)、格拉斯哥评分(GCS)、动脉血乳酸(LAC)、白蛋白(Alb)、肌酐(SCr)为重症肺炎患者预后不良的独立影响因素。由上述独立影响因素建立的预测模型回归方程为:Logit(P)=15.670-0.061X1-0.618X2+0.469X3-0.210X4+0.014X5,模型的C-index(即AUC)为0.928,HL拟合优度检验χ2(5)=7.366(P=0.498),Brier Score为0.109,Bootstrap方法内部验证的绝对误差为0.046。预测模型的AUC为0.928显著高于CURB-65评分(P<0.01),另其AUC高于APACHEⅡ评分、SOFA评分、PSI评分,差异无统计学意义(P>0.05)。经NRI、IDI分析显示预测模型相对APACHEⅡ评分、SOFA评分、PSI评分重新分类的连续性NRI分别为0.868(P=0.000)、0.966(P=0.000)、0.578(P<0.000),IDI分别为0.154(P<0.000)、0.119(P=0.020)、0.115(P=0.024)。预测模型的Brier Score低于上述4种评分系统。结论:MAP、GCS、LAC、SCr、Alb为影响重症肺炎患者预后的独立因素;由上述独立因素建立的nomogram预测模型具有良好的区分度及校准度,其评估重症肺炎患者预后准确性高,应用方便快捷,较传统评分系统有一定的改善效果,值得临床推广。
  • 加载中
  • [1]

    Hansen V,Oren E,Dennis LK,et al.Infectious Disease Mortality Trends in the United States,1980-2014[J].JAMA,2016,316(20):2149-2151.

    [2]

    中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279.

    [3]

    李晓燕,薄建萍.社区获得性肺炎诊疗新进展[J].国际呼吸杂志,2020,40(6):470-476.

    [4]

    Kolditz M,Ewig S,Klapdor B,et al.Community-acquired pneumonia as medical emergency:predictors of early deterioration[J].Thorax,2015,70(6):551-558.

    [5]

    Wang X,Jiao J,Wei R,et al.A new method to predict hospital mortality in severe community acquired pneumonia[J].Eur J Intern Med,2017,40:56-63.

    [6]

    Frenzen FS,Kutschan U,Meiswinkel N,et al.Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia[J].Clin Microbiol Infect,2018,24(3):306.e1-306.e6.

    [7]

    Demirel B.Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia[J].The Clinical Respiratory Journal,2018,12(3):991-995.

    [8]

    Damayanti N,Abidin A,Keliat EN.The correlation between albumin levels with 30 days mortality in community acquired pneumonia patients[J].Earth Environ Sci,2018,125:e012141.

    [9]

    Miyazaki H,Nagata N,Akagi T,et al.Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital:Serum albumin is not less important than pneumonia severity assessment scale[J].J Infect Chemother,2018,24(8):602-609.

    [10]

    Ramirez JA,Wiemken TL,Peyrani P,et al.Adults Hospitalized With Pneumonia in the United States:Incidence,Epidemiology,and Mortality[J].Clin Infect Dis,2017,65(11):1806-1812.

    [11]

    Rahimi-Levene N,Koren-Michowitz M,Zeidenstein R,et al.Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumonia[J].Medicine (Baltimore),2018,97(12):e0192.

    [12]

    Peyrani P,Ramirez J.Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia[J].Am J Med Sci,2017,353(5):421.

    [13]

    Kim MA,Park JS,Lee CW,et al.Pneumonia severity index in viral community acquired pneumonia in adults[J].PLoS One,2019,14(3):e0210102.

    [14]

    Kim MW,Lim JY,Oh SH.Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia[J].Scand J Clin Lab Invest,2017,77(7):486-492.

    [15]

    Murillo-Zamora E,Medina-González A,Zamora-Pérez L,et al.Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia[J].Med Clin (Barc),2018,150(3):99-103.

    [16]

    Alba AC,Agoritsas T,Walsh M,et al.Discrimination and Calibration of Clinical Prediction Models:Users' Guides to the Medical Literature[J].JAMA,2017,318(14):1377-1384.

    [17]

    Van Calster B,Nieboer D,Vergouwe Y,et al.A calibration hierarchy for risk models was defined:from utopia to empirical data[J].J Clin Epidemiol,2016,74:167-176.

    [18]

    Burke RE,Hess E,Barón AE,et al.Predicting Potential Adverse Events During a Skilled Nursing Facility Stay:A Skilled Nursing Facility Prognosis Score[J].J Am Geriatr Soc,2018,66(5):930-936.

    [19]

    Manouchehrinia A,Zhu F,Piani-Meier D,et al.Predicting risk of secondary progression in multiple sclerosis:A nomogram[J].Mult Scler,2019,25(8):1102-1112.

    [20]

    Cook NR.Quantifying the added value of new biomarkers:how and how not[J].Diagn Progn Res,2018,2:14.

    [21]

    Karaismailoglu E,Konar NM,Goksuluk D,et al.Factors effecting the model performance measures area under the ROC curve,net reclassification improvement and integrated discrimination improvement[J].Communications in Statistics-Simulation and Computation,2019,48(9):2586-2598.

  • 加载中
计量
  • 文章访问数:  133
  • PDF下载数:  348
  • 施引文献:  0
出版历程
收稿日期:  2020-06-18

目录